Australia markets closed

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.62+0.90 (+19.07%)
At close: 03:59PM EST
5.37 -0.25 (-4.45%)
After hours: 08:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 14.57M
Enterprise value -5.38M
Trailing P/E 51.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)64.48
Price/book (mrq)0.94
Enterprise value/revenue -88.22
Enterprise value/EBITDA 0.25

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 34.95%
S&P500 52-week change 326.89%
52-week high 39.01
52-week low 31.86
50-day moving average 33.24
200-day moving average 33.34

Share statistics

Avg vol (3-month) 313.94k
Avg vol (10-day) 340.25k
Shares outstanding 52.59M
Implied shares outstanding 62.59M
Float 82.02M
% held by insiders 16.81%
% held by institutions 155.02%
Shares short (15 Feb 2024) 46.44k
Short ratio (15 Feb 2024) 40.88
Short % of float (15 Feb 2024) 40.33%
Short % of shares outstanding (15 Feb 2024) 40.25%
Shares short (prior month 12 Jan 2024) 46.24k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 326 July 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-35,560.66%

Management effectiveness

Return on assets (ttm)-81.53%
Return on equity (ttm)-178.30%

Income statement

Revenue (ttm)61k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-21.81M
Diluted EPS (ttm)-236.13
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)20.37M
Total cash per share (mrq)7.86
Total debt (mrq)423k
Total debt/equity (mrq)2.73%
Current ratio (mrq)3.62
Book value per share (mrq)5.97

Cash flow statement

Operating cash flow (ttm)-18.07M
Levered free cash flow (ttm)-9.6M